S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.

about

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q55312135

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@en

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@nl

type

Item

label

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@en

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@nl

prefLabel

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@en

S-amlodipine plus chlorthalido ...... a randomized controlled trial.

@nl

P1476

S-amlodipine plus chlorthalido ...... a randomized controlled trial

@en

P2093

Eung Ju Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jae Cho

http://www.w3.org/2001/XMLSchema#string

Jin Joo Park

http://www.w3.org/2001/XMLSchema#string

Jinho Shin

http://www.w3.org/2001/XMLSchema#string

Jong-Min Song

http://www.w3.org/2001/XMLSchema#string

Joon-Han Shin

http://www.w3.org/2001/XMLSchema#string

Kyoo-Rok Han

http://www.w3.org/2001/XMLSchema#string

Sang-Ho Jo

http://www.w3.org/2001/XMLSchema#string

Soo-Joong Kim

http://www.w3.org/2001/XMLSchema#string

Sung-Ji Park

http://www.w3.org/2001/XMLSchema#string

P2860

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Current status and characteristics of hypertension control in community resident elderly Korean people: data from a Korean longitudinal study on health and aging (KLoSHa study).

Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study).

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Telmisartan to prevent recurrent stroke and cardiovascular events.

P2888

s13063-018-2636-1

P304

324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-018-2636-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dong-Ju Choi

P577

2018-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105005079

http://www.w3.org/2001/XMLSchema#string

P698

29925421

http://www.w3.org/2001/XMLSchema#string

P932

6011241

http://www.w3.org/2001/XMLSchema#string